Chemed Corp. Stock Price, News & Analysis (NYSE:CHE)

$231.61 -1.46 (-0.63 %)
(As of 11/17/2017 10:55 AM ET)
Previous Close$231.61
Today's Range$235.01 - $231.00
52-Week Range$145.35 - $235.96
Volume95,999 shs
Average Volume94,289 shs
Market Capitalization$3.70076 billion
P/E Ratio28.55
Dividend Yield0.48%
Beta1.14

About Chemed Corp. (NYSE:CHE)

Chemed Corp. logoChemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.


Industry, Sector and Symbol:
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: Health Care Services
  • Sector: Medical
  • Symbol: NYSE:CHE
  • CUSIP: 16359R10
  • Web: www.chemed.com
Debt:
  • Debt-to-Equity Ratio: 0.15%
  • Current Ratio: 0.50%
  • Quick Ratio: 0.48%
Price-To-Earnings:
  • Trailing P/E Ratio: 28.55
  • Forward P/E Ratio: 48.97
  • P/E Growth: 4.9
Sales & Book Value:
  • Annual Sales: $1.57688 billion
  • Price / Sales: 2.35
  • Cash Flow: $9.44 per share
  • Price / Cash: 24.54
  • Book Value: $29.92 per share
  • Price / Book: 7.74
Dividend:
  • Annual Dividend: $1.12
  • Dividend Yield: 0.5%
Profitability:
  • Trailing EPS: $4.50
  • Net Income: $108.74 million
  • Net Margins: 4.62%
  • Return on Equity: 27.69%
  • Return on Assets: 15.16%
Misc:
  • Employees: 14,613
  • Outstanding Shares: 15,970,000
 

Frequently Asked Questions for Chemed Corp. (NYSE:CHE)

What is Chemed Corp.'s stock symbol?

Chemed Corp. trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed Corp. pay dividends? What is the dividend yield for Chemed Corp.?

Chemed Corp. announced a quarterly dividend on Friday, November 3rd. Shareholders of record on Monday, November 13th will be paid a dividend of $0.28 per share on Monday, December 4th. This represents a $1.12 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date of this dividend is Friday, November 10th. View Chemed Corp.'s Dividend History.

How will Chemed Corp.'s stock buyback program work?

Chemed Corp. declared that its Board of Directors has initiated a share repurchase program on Monday, April 10th 2017, which authorizes the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 3.3% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.

How were Chemed Corp.'s earnings last quarter?

Chemed Corp. (NYSE:CHE) issued its earnings results on Thursday, October, 26th. The company reported $2.15 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.00 by $0.15. The company earned $417.40 million during the quarter, compared to analysts' expectations of $414.34 million. Chemed Corp. had a return on equity of 27.69% and a net margin of 4.62%. Chemed Corp.'s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.73 earnings per share. View Chemed Corp.'s Earnings History.

When will Chemed Corp. make its next earnings announcement?

Chemed Corp. is scheduled to release their next quarterly earnings announcement on Wednesday, February, 21st 2018. View Earnings Estimates for Chemed Corp..

What guidance has Chemed Corp. issued on next quarter's earnings?

Chemed Corp. updated its FY17 earnings guidance on Thursday, October, 26th. The company provided EPS guidance of $8.35-$8.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.19.

Where is Chemed Corp.'s stock going? Where will Chemed Corp.'s stock price be in 2017?

3 brokers have issued 1 year price objectives for Chemed Corp.'s stock. Their forecasts range from $225.00 to $232.00. On average, they anticipate Chemed Corp.'s share price to reach $228.50 in the next year. View Analyst Ratings for Chemed Corp..

Who are some of Chemed Corp.'s key competitors?

Who are Chemed Corp.'s key executives?

Chemed Corp.'s management team includes the folowing people:

  • George J. Walsh III, Independent Chairman of the Board (Age 71)
  • Kevin J. McNamara, President, Chief Executive Officer, Director (Age 63)
  • David Patrick Williams, Chief Financial Officer, Executive Vice President (Age 56)
  • Spencer S. Lee, Executive Vice President (Age 61)
  • Nicholas Michael Westfall, Executive Vice President (Age 38)
  • Michael D. Witzeman, Principal Accounting Officer, Controller (Age 46)
  • Thomas Charles Hutton, Director (Age 66)
  • Joel F. Gemunder, Independent Director (Age 77)
  • Patrick P. Grace, Independent Director (Age 61)
  • Walter L. Krebs, Independent Director (Age 84)

Who owns Chemed Corp. stock?

Chemed Corp.'s stock is owned by many different of institutional and retail investors. Top institutional investors include Neuberger Berman Group LLC (6.20%), Riverbridge Partners LLC (3.54%), Gamco Investors INC. ET AL (3.30%), Fisher Asset Management LLC (3.10%), Van Berkom & Associates Inc. (2.47%) and Dimensional Fund Advisors LP (2.47%). Company insiders that own Chemed Corp. stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed Corp..

Who sold Chemed Corp. stock? Who is selling Chemed Corp. stock?

Chemed Corp.'s stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Schroder Investment Management Group, Boston Partners, Van Berkom & Associates Inc., Gamco Investors INC. ET AL, Neuberger Berman Group LLC, Seizert Capital Partners LLC and Bank of New York Mellon Corp. Company insiders that have sold Chemed Corp. company stock in the last year include Arthur V Tucker Jr, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed Corp..

Who bought Chemed Corp. stock? Who is buying Chemed Corp. stock?

Chemed Corp.'s stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Old Mutual Global Investors UK Ltd., APG Asset Management N.V., Shell Asset Management Co., Wells Fargo & Company MN, Russell Investments Group Ltd., Chicago Equity Partners LLC and Mutual of America Capital Management LLC. Company insiders that have bought Chemed Corp. stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed Corp..

How do I buy Chemed Corp. stock?

Shares of Chemed Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed Corp.'s stock price today?

One share of Chemed Corp. stock can currently be purchased for approximately $231.61.

How big of a company is Chemed Corp.?

Chemed Corp. has a market capitalization of $3.70076 billion and generates $1.57688 billion in revenue each year. The company earns $108.74 million in net income (profit) each year or $4.50 on an earnings per share basis. Chemed Corp. employs 14,613 workers across the globe.

How can I contact Chemed Corp.?

Chemed Corp.'s mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.


MarketBeat Community Rating for Chemed Corp. (NYSE CHE)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  157 (Vote Underperform)
Total Votes:  269
MarketBeat's community ratings are surveys of what our community members think about Chemed Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Chemed Corp. (NYSE:CHE)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 2 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $228.50 (1.34% downside)

Consensus Price Target History for Chemed Corp. (NYSE:CHE)

Price Target History for Chemed Corp. (NYSE:CHE)

Analysts' Ratings History for Chemed Corp. (NYSE:CHE)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/31/2017Royal Bank Of CanadaBoost Price TargetPositive -> Sector Perform$232.00N/AView Rating Details
10/27/2017Oppenheimer Holdings, Inc.Boost Price TargetOutperform$220.00 -> $225.00N/AView Rating Details
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
8/13/2017National Bank FinancialUpgradeSector Perform Market Weight -> Outperform Market WeightN/AView Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
(Data available from 11/18/2015 forward)

Earnings

Earnings History and Estimates Chart for Chemed Corp. (NYSE:CHE)

Earnings by Quarter for Chemed Corp. (NYSE:CHE)

Earnings History by Quarter for Chemed Corp. (NYSE CHE)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/13/2018$2.27N/AView Earnings Details
10/26/2017Q3 2017$2.00$2.15$414.34 million$417.40 millionViewN/AView Earnings Details
7/25/2017Q2 2017$1.89$2.15$407.56 million$415.06 millionViewN/AView Earnings Details
4/26/2017Q1 2017$1.78$1.82$399.75 million$405.90 millionViewN/AView Earnings Details
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.35$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.65$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.34$1.40$360.00 million$358.40 millionViewListenView Earnings Details
8/7/2014$0.32$0.30$319.70 million$310.06 millionViewN/AView Earnings Details
7/23/2014Q214$1.31$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.23$1.32$256.77 million$358.30 millionViewListenView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Chemed Corp. (NYSE:CHE)
2017 EPS Consensus Estimate: $7.83
2018 EPS Consensus Estimate: $8.61
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.77$1.77$1.77
Q2 20171$1.89$1.89$1.89
Q3 20172$1.97$2.02$2.00
Q4 20172$2.12$2.23$2.18
Q1 20181$1.95$1.95$1.95
Q2 20181$2.09$2.09$2.09
Q3 20181$2.14$2.14$2.14
Q4 20181$2.43$2.43$2.43
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Chemed Corp. (NYSE:CHE)

Next Dividend:12/4/2017
Annual Dividend:$1.12
Dividend Yield:0.48%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:24.89% (Trailing 12 Months of Earnings)
23.68% (Based on This Year's Estimates)
12.57% (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Chemed Corp. (NYSE:CHE)

Dividend History by Quarter for Chemed Corp. (NYSE CHE)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/3/2017Quarterly$0.280.48%11/10/201711/13/201712/4/2017
9/22/2017Monthly$0.109/28/20179/29/201710/31/2017
8/23/2017Monthly$0.108/29/20178/31/20179/29/2017
8/4/2017quarterly$0.280.57%8/10/20178/14/20179/1/2017
7/21/2017Monthly$0.107/27/20177/31/20178/31/2017
6/22/2017Monthly$0.106/28/20176/30/20177/31/2017
5/15/2017Quarterly$0.260.51%5/23/20175/25/20176/14/2017
2/17/2017quarterly$0.260.59%2/23/20172/27/20173/20/2017
11/4/2016quarterly$0.260.76%11/9/201611/14/201612/5/2016
8/5/2016quarterly$0.260.72%8/11/20168/15/20169/2/2016
5/16/2016quarterly$0.240.76%5/24/20165/26/20166/15/2016
2/19/2016quarterly$0.240.75%2/25/20162/29/20163/21/2016
11/6/2015quarterly$0.240.63%11/12/201511/16/201512/7/2015
8/7/2015quarterly$0.240.63%8/13/20158/17/20159/4/2015
5/18/2015quarterly$0.220.71%5/26/20155/28/20156/17/2015
2/20/2015quarterly$0.220.77%2/26/20153/2/20153/23/2015
11/7/2014quarterly$0.220.81%11/13/201411/17/201412/8/2014
8/11/2014quarterly$0.220.88%8/14/20148/18/20149/13/2014
8/8/2014quarterly$0.228/14/20148/18/20149/3/2014
5/19/2014quarterly$0.200.91%5/27/20145/29/20146/18/2014
2/21/2014quarterly$0.200.94%2/27/20143/3/20143/24/2014
11/8/2013quarterly$0.201.13%11/14/201311/18/201312/9/2013
8/2/2013quarterly$0.201.1%8/8/20138/12/20139/3/2013
5/20/2013quarterly$0.181.05%5/28/20135/30/20136/19/2013
2/20/2013quarterly$0.180.92%2/28/20133/4/20133/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Chemed Corp. (NYSE CHE)

Insider Ownership Percentage: 4.90%
Institutional Ownership Percentage: 96.58%
Insider Trades by Quarter for Chemed Corp. (NYSE:CHE)
Institutional Ownership by Quarter for Chemed Corp. (NYSE:CHE)

Insider Trades by Quarter for Chemed Corp. (NYSE CHE)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2017Michael D WitzemanVPSell1,579$235.00$371,065.00View SEC Filing  
11/15/2017Kevin J McnamaraCEOSell5,000$232.59$1,162,950.00View SEC Filing  
11/15/2017Spencer S LeeInsiderSell1,000$232.27$232,270.00View SEC Filing  
11/13/2017Nicholas Michael WestfallInsiderSell10,000$231.00$2,310,000.00View SEC Filing  
11/8/2017Naomi C DallobVPSell1,900$231.00$438,900.00View SEC Filing  
11/2/2017Donald E SaundersDirectorSell500$227.75$113,875.00View SEC Filing  
11/2/2017Spencer S LeeEVPSell1,000$228.45$228,450.00View SEC Filing  
10/31/2017Kevin J McnamaraCEOSell10,000$223.42$2,234,200.00View SEC Filing  
10/31/2017Naomi C DallobVPSell750$222.09$166,567.50View SEC Filing  
10/2/2017Patrick P GraceDirectorSell500$201.48$100,740.00View SEC Filing  
9/1/2017Spencer S LeeInsiderSell1,000$197.46$197,460.00View SEC Filing  
7/28/2017Kevin J McnamaraInsiderSell15,000$201.16$3,017,400.00View SEC Filing  
6/26/2017George J Walsh IIIDirectorBuy1,000$204.56$204,560.00View SEC Filing  
5/4/2017Donald E SaundersDirectorBuy94$205.59$19,325.46View SEC Filing  
5/3/2017Donald E SaundersDirectorSell400$204.85$81,940.00View SEC Filing  
5/2/2017Kevin J McnamaraInsiderSell4,000$205.11$820,440.00View SEC Filing  
5/1/2017Spencer S LeeInsiderSell1,000$202.47$202,470.00View SEC Filing  
3/3/2017Kevin J McnamaraInsiderSell7,000$181.74$1,272,180.00View SEC Filing  
3/2/2017Arthur V Tucker JrVPSell2,266$181.00$410,146.00View SEC Filing  
2/27/2017Arthur V Tucker JrVPSell8,878$179.21$1,591,026.38View SEC Filing  
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.00View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.00View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.00View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.00View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.00View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.00View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.32View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.81View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.78View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.00View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.00View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.00View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.00View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.00View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.00View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.00View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.36View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.00View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.00View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.80View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.00View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Chemed Corp. (NYSE:CHE)

Latest Headlines for Chemed Corp. (NYSE CHE)

Source:
DateHeadline
Insider Selling: Chemed Corp. (CHE) VP Sells 1,579 Shares of StockInsider Selling: Chemed Corp. (CHE) VP Sells 1,579 Shares of Stock
www.americanbankingnews.com - November 17 at 1:48 PM
Chemed Corp. (CHE) Insider Sells $232,270.00 in StockChemed Corp. (CHE) Insider Sells $232,270.00 in Stock
www.americanbankingnews.com - November 16 at 4:48 PM
Kevin J. Mcnamara Sells 5,000 Shares of Chemed Corp. (CHE) StockKevin J. Mcnamara Sells 5,000 Shares of Chemed Corp. (CHE) Stock
www.americanbankingnews.com - November 16 at 4:22 PM
ETFs with exposure to Chemed Corp. : November 14, 2017ETFs with exposure to Chemed Corp. : November 14, 2017
finance.yahoo.com - November 14 at 5:41 PM
Chemed Corp. (CHE) Insider Sells $2,310,000.00 in StockChemed Corp. (CHE) Insider Sells $2,310,000.00 in Stock
www.americanbankingnews.com - November 14 at 1:32 PM
Head to Head Comparison: Chemed Corp. (CHE) and The Joint Corp. (JYNT)Head to Head Comparison: Chemed Corp. (CHE) and The Joint Corp. (JYNT)
www.americanbankingnews.com - November 9 at 10:26 AM
Chemed Corp. (CHE) VP Naomi C. Dallob Sells 1,900 SharesChemed Corp. (CHE) VP Naomi C. Dallob Sells 1,900 Shares
www.americanbankingnews.com - November 8 at 12:40 PM
Zacks: Analysts Expect Chemed Corp. (CHE) Will Post Quarterly Sales of $423.56 MillionZacks: Analysts Expect Chemed Corp. (CHE) Will Post Quarterly Sales of $423.56 Million
www.americanbankingnews.com - November 8 at 2:06 AM
 Analysts Expect Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share Analysts Expect Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share
www.americanbankingnews.com - November 6 at 11:26 PM
Insider Selling: Chemed Corp. (CHE) Director Sells 500 Shares of StockInsider Selling: Chemed Corp. (CHE) Director Sells 500 Shares of Stock
www.americanbankingnews.com - November 6 at 3:34 PM
Chemed Corp. to Issue Dividend of $0.28 (CHE)Chemed Corp. to Issue Dividend of $0.28 (CHE)
www.americanbankingnews.com - November 4 at 10:56 AM
Chemed Corporation Declares Quarterly Dividend of 28 CentsChemed Corporation Declares Quarterly Dividend of 28 Cents
finance.yahoo.com - November 4 at 7:40 AM
Insider Selling: Chemed Corp. (CHE) EVP Sells 1,000 Shares of StockInsider Selling: Chemed Corp. (CHE) EVP Sells 1,000 Shares of Stock
www.americanbankingnews.com - November 3 at 2:44 PM
Chemed Corp. (CHE) Given Consensus Recommendation of "Hold" by BrokeragesChemed Corp. (CHE) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 3 at 5:46 AM
ETFs with exposure to Chemed Corp. : November 2, 2017ETFs with exposure to Chemed Corp. : November 2, 2017
finance.yahoo.com - November 2 at 6:00 PM
Zacks Investment Research Upgrades Chemed Corp. (CHE) to "Buy"Zacks Investment Research Upgrades Chemed Corp. (CHE) to "Buy"
www.americanbankingnews.com - November 2 at 2:20 PM
KeyCorp Weighs in on Chemed Corp.s FY2017 Earnings (CHE)KeyCorp Weighs in on Chemed Corp.'s FY2017 Earnings (CHE)
www.americanbankingnews.com - November 2 at 9:28 AM
Chemed Corp. :CHE-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Chemed Corp. :CHE-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 1 at 5:54 PM
Chemed Corp. (CHE) VP Sells $166,567.50 in StockChemed Corp. (CHE) VP Sells $166,567.50 in Stock
www.americanbankingnews.com - November 1 at 2:44 PM
Kevin J. Mcnamara Sells 10,000 Shares of Chemed Corp. (CHE) StockKevin J. Mcnamara Sells 10,000 Shares of Chemed Corp. (CHE) Stock
www.americanbankingnews.com - November 1 at 2:44 PM
KeyCorp Equities Analysts Increase Earnings Estimates for Chemed Corp. (CHE)KeyCorp Equities Analysts Increase Earnings Estimates for Chemed Corp. (CHE)
www.americanbankingnews.com - November 1 at 12:00 PM
BRIEF-Chemed reaches final agreement to end civil litigation & false claims act brought by U.S. DOJ in May 2013BRIEF-Chemed reaches final agreement to end civil litigation & false claims act brought by U.S. DOJ in May 2013
www.reuters.com - October 31 at 6:19 PM
Chemed Settles DOJ LitigationChemed Settles DOJ Litigation
finance.yahoo.com - October 31 at 6:19 PM
One of Cincinnatis largest public companies agrees to $75M settlement with fedsOne of Cincinnati's largest public companies agrees to $75M settlement with feds
finance.yahoo.com - October 31 at 6:19 PM
Chemed to pay $75 mln over false claims lawsuit -Justice DeptChemed to pay $75 mln over false claims lawsuit -Justice Dept
finance.yahoo.com - October 31 at 1:51 AM
Chemed to pay $75 million over false claims lawsuit: Justice DeptChemed to pay $75 million over false claims lawsuit: Justice Dept
www.reuters.com - October 30 at 8:50 PM
Stocks Showing Market Leadership: Chemed Earns 90 RS RatingStocks Showing Market Leadership: Chemed Earns 90 RS Rating
finance.yahoo.com - October 30 at 3:49 PM
Chemed Corporation (CHE) CEO Kevin McNamara Q3 2017 Results - Earnings Call TranscriptChemed Corporation (CHE) CEO Kevin McNamara Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - October 28 at 10:28 PM
Oppenheimer Holdings, Inc. Increases Chemed Corp. (CHE) Price Target to $225.00Oppenheimer Holdings, Inc. Increases Chemed Corp. (CHE) Price Target to $225.00
www.americanbankingnews.com - October 28 at 3:34 PM
Edited Transcript of CHE earnings conference call or presentation 27-Oct-17 2:00pm GMTEdited Transcript of CHE earnings conference call or presentation 27-Oct-17 2:00pm GMT
finance.yahoo.com - October 28 at 12:51 AM
Chemed Corporation to Host Earnings CallChemed Corporation to Host Earnings Call
finance.yahoo.com - October 27 at 7:51 PM
Chemed Corp. (CHE) Posts  Earnings Results, Beats Expectations By $0.15 EPSChemed Corp. (CHE) Posts Earnings Results, Beats Expectations By $0.15 EPS
www.americanbankingnews.com - October 26 at 6:30 PM
BRIEF-Chemed reports Q3 earnings per share $2.13BRIEF-Chemed reports Q3 earnings per share $2.13
www.reuters.com - October 26 at 5:24 PM
How Do Analysts See Chemed Corporation (CHE) Performing In The Year Ahead?How Do Analysts See Chemed Corporation (CHE) Performing In The Year Ahead?
finance.yahoo.com - October 26 at 5:24 PM
Chemed Reports Third-Quarter 2017 ResultsChemed Reports Third-Quarter 2017 Results
finance.yahoo.com - October 26 at 5:24 PM
Chemed Corp. (CHE) Issues FY17 Earnings GuidanceChemed Corp. (CHE) Issues FY17 Earnings Guidance
www.americanbankingnews.com - October 26 at 5:20 PM
$414.87 Million in Sales Expected for Chemed Corp. (CHE) This Quarter$414.87 Million in Sales Expected for Chemed Corp. (CHE) This Quarter
www.americanbankingnews.com - October 20 at 9:06 AM
Chemed Corp. (CHE) Set to Announce Quarterly Earnings on ThursdayChemed Corp. (CHE) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - October 19 at 1:24 AM
$2.00 Earnings Per Share Expected for Chemed Corp. (CHE) This Quarter$2.00 Earnings Per Share Expected for Chemed Corp. (CHE) This Quarter
www.americanbankingnews.com - October 18 at 9:43 AM
Analyzing Chemed Corp. (CHE) & TeamHealth Holdings (TMH)Analyzing Chemed Corp. (CHE) & TeamHealth Holdings (TMH)
www.americanbankingnews.com - October 11 at 10:12 PM
Reviewing Chemed Corp. (CHE) & Mednax (MD)Reviewing Chemed Corp. (CHE) & Mednax (MD)
www.americanbankingnews.com - October 10 at 2:14 PM
Chemed Corp. (CHE) Receives Consensus Recommendation of "Hold" from BrokeragesChemed Corp. (CHE) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - October 9 at 2:42 AM
Patrick P. Grace Sells 500 Shares of Chemed Corp. (CHE) StockPatrick P. Grace Sells 500 Shares of Chemed Corp. (CHE) Stock
www.americanbankingnews.com - October 2 at 4:34 PM
Chemed Corp. (CHE) Expected to Post Quarterly Sales of $414.87 MillionChemed Corp. (CHE) Expected to Post Quarterly Sales of $414.87 Million
www.americanbankingnews.com - October 1 at 8:56 AM
 Analysts Expect Chemed Corp. (CHE) to Announce $2.00 Earnings Per Share Analysts Expect Chemed Corp. (CHE) to Announce $2.00 Earnings Per Share
www.americanbankingnews.com - September 29 at 12:28 PM
Heres Why You Should Add Chemed (CHE) to Your PortfolioHere's Why You Should Add Chemed (CHE) to Your Portfolio
finance.yahoo.com - September 22 at 4:08 PM
Amedisys or Chemed: Which is a Better Investment Choice?Amedisys or Chemed: Which is a Better Investment Choice?
finance.yahoo.com - September 22 at 10:07 AM
Why Should Investors Add Amedisys (AMED) to Their Portfolio?Why Should Investors Add Amedisys (AMED) to Their Portfolio?
finance.yahoo.com - September 21 at 4:58 PM
Here's Why You Should Add Chemed (CHE) to Your PortfolioHere's Why You Should Add Chemed (CHE) to Your Portfolio
finance.yahoo.com - September 21 at 10:45 AM
Chemed Getting Closer To Key Technical MeasureChemed Getting Closer To Key Technical Measure
finance.yahoo.com - September 18 at 3:41 PM

Social Media

Financials

Chart

Chemed Corp. (NYSE CHE) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.